Predict your next investment

Bio2 Technologies company logo
HEALTHCARE | Medical Devices & Equipment / Therapeutic Devices
bio2tech.com

See what CB Insights has to offer

Stage

Debt | Alive

Total Raised

$13.46M

Last Raised

$3.19M | 1 yr ago

About Bio2 Technologies

Bio2 is a medical device company developing and commercializing tissue engineering scaffolds for orthopedic applications.

Bio2 Technologies Headquarter Location

12-R Cabot Road

Woburn, Massachusetts, 01801,

United States

781-569-0559

Latest Bio2 Technologies News

Bio2 Technologies recruits first patient for Vitrium cervical implant trial

Aug 6, 2019

Bio2 Technologies has announced the first implantation of an index patient in its Vitrium cervical interbody clinical trial Image: Vitrium cervical fusion investigational device. Bio2 Technologies has recruited the first patient in the randomised, multi-centre and clinical trial of the Vitrium cervical interbody device. The company has secured an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to carry out the study after pre-clinical studies showed Vitrium implants are substituted with a newly regenerated bone while exhibiting sufficient strength for use in load-bearing reconstructive surgeries such as spinal fusion. Vitrium cervical interbody clinical trial Vitrium is a new class of resorbable orthobiomaterial with broad application in musculo­skeletal surgery. The company has announced the first implantation of an index patient in the Vitrium cervical interbody clinical study. The Orthopaedic Institute of Western Kentucky’s Dr Brandon Strenge conducted the procedure. Strenge said: “I am very excited to be a part of this study evaluating a device that harnesses the patient’s own regenerative process to achieve a fusion without metal or plastic left behind.” The company will enroll up to 168 patients in a prospective study to compare the Vitrium cervical implant to allograft (cadaver bone). Vitrium will enable the surgeon to reconstruct bony anatomy without the clinical compromises inherent in currently available technologies. Vitrium, constructed exclusively of bioactive glass, is porous, load-bearing, osteoconductive and bioactive. Vitrium resorbable implants serve as an alternative to the machined allograft, porous metal, and PEEK. According to the company, Vitrium interbody devices are fully replaced by bone resulting in TBF (Total Biologic Fusion). Bio2 Technologies chief operating officer Dr Janet Krevolin said: “We’re excited to have the first patient implanted with the Vitrium Cervical Interbody Device. “We look forward to returning to the gold standard outcome of a total biologic fusion with no foreign material remaining in the disc space.” Based in Woburn of Massachusetts, Bio2 Technologies is involved in the development of advanced orthobiomaterials through using an advanced process. It also commercialises implantable devices constructed from these materials for distribution through exclusive marketing partners. Do you have interesting content to share with us? Enter your email address so we can get in touch. Related Article

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bio2 Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bio2 Technologies is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

10,972 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Bio2 Technologies Patents

Bio2 Technologies has filed 11 patents.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Prosthetics
  • Biomaterials
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/20/2018

3/30/2021

Orthopedic surgical procedures, Bones of the vertebral column, Implants (medicine), Prosthetics, Neurosurgery

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

3/20/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/30/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Orthopedic surgical procedures, Bones of the vertebral column, Implants (medicine), Prosthetics, Neurosurgery

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.